Heart and brain health study
Part of Heart & circulation, Mental health clinical trials.
This study looks at how heart health and brain health are connected. It may help improve thinking and memory in people with mild memory problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 21 years old or older.
- You must be willing to take part and give your consent.
- If you join the memory part of the study, you need to have mild memory or thinking issues (like a low score on a memory test).
- You cannot have a serious brain disease, major mental illness, or a terminal illness.
- You cannot have severe depression, anxiety, or stress that might make it hard to take part.
- If you are pregnant or breastfeeding, you cannot take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at people over age 50 who have mild thinking or memory problems but do not have dementia by standard clinical criteria. It tests how these early changes are characterized and measured using exams such as blood tests and brain scans, which may help improve understanding and future care.
This study tests whether a healthy lifestyle program—combining nutrition advice and exercise training—can help protect brain health in people with early memory problems. It may be a good fit if you have mild cognitive concerns and are ready to make positive changes.
This study looks at what factors might increase the risk of memory and thinking problems in people with coronary heart disease. It includes testing your memory and metabolism during a hospital stay.
This study tests a computer-based brain-training program designed to improve memory and thinking skills in older adults with mild cognitive impairment (MCI). It aims to see if these exercises can help keep the brain healthy and slow down memory decline.
This study looks at memory and thinking changes using questionnaires, memory testing, and brain scans. It may help researchers better understand neurodegeneration and dementia and how these problems show up over time.
This study looks at blood and imaging markers (biomarkers) to better understand and diagnose dementia and mild cognitive impairment. It aims to improve early detection and may help guide future treatments.
Hear when a new Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.